Surgical Therapy of Right‐Sided Infective Endocarditis: Insights From the Multicenter Project of Analysis of Infective Endocarditis in Germany (CAMPAIGN) Study Group
Journal of Cardiac Surgery · 2026-01 · 2026 (1)
DOI: 10.1155/jocs/1154574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Surgery, online erschienen am 21.06.2026. Verfasst von Asen Petrov und 16 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Right‐sided infective endocarditis (RSIE) is a rare entity seldom requiring surgical therapy. This study compares the outcome following surgery in cases of isolated RSIE (iRSIE) and cases with concomitant left‐sided infective endocarditis (LSIE).
Methods
A retrospective analysis was performed on the database of the Clinical Multicenter Project for Analysis of Infective Endocarditis in Germany (CAMPAIGN) for the time period 2011–2018 at 6 German centres, comprising 2225 consecutive patients undergoing heart valve surgery. RSIE were further stratified according to the presence of LSIE: iRSIE and concomitant LSIE (RLSIE). Primary outcomes were 30‐day mortality and estimated 5‐year survival.
Results
The 103 (4.6% of all IE) patients who underwent surgery for RSIE were divided into iRSIE ( n = 56, 54.4%) and RLSIE ( n = 47, 45.6%). Patient age was 56.7 vs. 62.9 years, p = 0.07 in RSIE and RLSIE, respectively. Further baseline characteristics including gender distribution, left ventricular ejection fraction and comorbidities did not differ significantly. The most common causative microorganisms were Staphylococcus species (58.9% vs. 46.8%, p = 0.24). Despite the higher operative complexity of the RLSIE group, postoperative course and long‐term outcomes did not differ significantly—perioperative mortality was 16.8% vs. 16.7%; 29.8% vs. 35.2% at 1 year and 46.7% vs. 59.9% at 5 years in RSIE and RLSIE, respectively ( p = 0.57).
Conclusions
In a cohort of elderly patients with high preoperative risk factors undergoing surgical therapy for RSIE, outcome is not substantially determined by the presence of concomitant LSIE.
Zitieren
APA
Petrov, A., Angelis, V. D., Marin-Cuartas, M., Weber, C., Lichtenberg, A., Hagl, C., Aubin, H., Diab, M., Luehr, M., Akhyari, P., Saha, S., Doenst, T., Wahlers, T., Borger, M. A., Misfeld, M., Matschke, K., & Tugtekin, S. (2026). Surgical Therapy of Right‐Sided Infective Endocarditis: Insights From the Multicenter Project of Analysis of Infective Endocarditis in Germany (CAMPAIGN) Study Group. Journal of Cardiac Surgery, 2026(1). https://doi.org/10.1155/jocs/1154574
Vancouver
Petrov A, Angelis VD, Marin-Cuartas M, Weber C, Lichtenberg A, Hagl C, et al. Surgical Therapy of Right‐Sided Infective Endocarditis: Insights From the Multicenter Project of Analysis of Infective Endocarditis in Germany (CAMPAIGN) Study Group. Journal of Cardiac Surgery. 2026;2026(1). doi:10.1155/jocs/1154574
BibTeX
@article{Petrov2026,
author = {Petrov, Asen and Angelis, Veronica De and Marin-Cuartas, Mateo and Weber, Carolyn and Lichtenberg, Artur and Hagl, Christian and Aubin, Hug and Diab, Mahmoud and Luehr, Maximilian and Akhyari, Payam and Saha, Shekhar and Doenst, Torsten and Wahlers, Thorsten and Borger, Michael A. and Misfeld, Martin and Matschke, Klaus and Tugtekin, Sems-Malte},
title = {Surgical Therapy of Right‐Sided Infective Endocarditis: Insights From the Multicenter Project of Analysis of Infective Endocarditis in Germany (CAMPAIGN) Study Group},
journal = {Journal of Cardiac Surgery},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jocs/1154574}
}
EUVIMED